Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/0323 : 25Edgar (US Regulatory)Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialNYSE:LLLL Flooring Holdings Inc
2024/06/0323 : 25Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:MSTLWMorgan Stanley (PK)
2024/06/0323 : 25PR Newswire (US)Sport-Brella Launches Suncave Shelter
2024/06/0323 : 25PR Newswire (Canada)MEDIA ADVISORY - Federal cabinet ministers to hold a media availability on the 2023-24 Federal Pathway Annual Progress Report
2024/06/0323 : 24Business WireCyble Welcomes Cybersecurity Expert Steve Ingram to Advisory Board
2024/06/0323 : 24PR Newswire (Canada)EXO : HORAIRES d'ÉTÉ EN VIGUEUR À COMPTER DU 1ER JUILLET DANS LE SECTEUR CHAMBLY-RICHELIEU-CARIGNAN
2024/06/0323 : 23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesUSOTC:ALLJLAllstate Corporation (PK)
2024/06/0323 : 23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AZNAstraZeneca PLC
2024/06/0323 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WORWorthington Enterprises Inc
2024/06/0323 : 23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARMARM Holdings PLC
2024/06/0323 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SNEXStoneX Group Inc
2024/06/0323 : 21Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:MSTLWMorgan Stanley (PK)
2024/06/0323 : 20Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:MSTLWMorgan Stanley (PK)
2024/06/0323 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RGRSturm Ruger and Co
2024/06/0323 : 19PR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - LABZ
2024/06/0323 : 18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:MSTLWMorgan Stanley (PK)
2024/06/0323 : 18Business WireLitigation Partner Marc Krickbaum Returns to Winston & Strawn After Stint as Deputy Special Counsel
2024/06/0323 : 18PR Newswire (US)US LBM NAMES RUSSELL TIEJEMA EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
2024/06/0323 : 17GlobeNewswire Inc.General Atomics Innovations Drive Breakthroughs in Inertial Fusion and Enable Repeated Fusion Ignition Experiments at the National Ignition Facility
2024/06/0323 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RGRSturm Ruger and Co
2024/06/0323 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVAAvista Corp
2024/06/0323 : 16GlobeNewswire Inc.Kymanox® Announces Facility Expansion to Enhance CGxP Space and Laboratory Service Offerings
2024/06/0323 : 16PR Newswire (US)Bakery Enzyme Market to Attain $1.73 Billion at 5.1% CAGR by 2034 | Fact.MR Report
2024/06/0323 : 16PR Newswire (US)Advantice Health Appoints Duda Kertesz as New CEO
2024/06/0323 : 16PR Newswire (US)Bakery Enzyme Market to Attain $1.73 Billion at 5.1% CAGR by 2034 | Fact.MR Report
2024/06/0323 : 16PR Newswire (US)Probiotics Market to Reach $100.10 Billion by 2031 - Exclusive Report by Meticulous Research®
2024/06/0323 : 16PR Newswire (US)Probiotics Market to Reach $100.10 Billion by 2031 - Exclusive Report by Meticulous Research®
2024/06/0323 : 15Edgar (US Regulatory)Form 8-K - Current reportAMEX:AIMAIM ImmunoTech Inc
2024/06/0323 : 15Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:MSTLWMorgan Stanley (PK)
2024/06/0323 : 15GlobeNewswire Inc.CORRECTION - First Federal Savings Bank Announces the Appointment of Two New Board Members Effective May 2024